SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-058459
Filing Date
2018-02-26
Accepted
2018-02-26 16:07:07
Documents
6
Period of Report
2018-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d514107d6k.htm 6-K 16294
2 EX-1.1 d514107dex11.htm EX-1.1 216711
3 EX-3.1 d514107dex31.htm EX-3.1 232546
4 EX-5.1 d514107dex51.htm EX-5.1 23322
5 GRAPHIC g514107img01.jpg GRAPHIC 21435
6 GRAPHIC g514107img02.jpg GRAPHIC 5587
  Complete submission text file 0001193125-18-058459.txt   527341
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 18640564
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1